Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 11:13 PM
Study NCT ID:
NCT01660360
Status:
COMPLETED
Last Update Posted:
2014-01-29
First Post:
2012-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
Sponsor:
PharmAbcine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-06
First Submit QC Date:
None
Study First Post Date:
2012-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-27
Last Update Post Date:
2014-01-29
Last Update Post Date Type:
ESTIMATED